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Objectives. This study was undertaken to investigate the inci-
dence of posttransplant recoarctation of the aorta, delineate the
mode of presentation, identify risk factors that predict recoarcta-
tion and examine the results of intervention for posttransplant
recoarctation.
Background. Patients with aortic arch hypoplasia require ex-
tended arch reconstruction at transplant, with an inherent possi-
bility of subsequent recoarctation of the aorta.
Methods. This was a retrospective review of all children (age <18
years) who underwent cardiac transplantation over a 10-year period.
Collected data included pretransplant diagnosis, details of the trans-
plant procedure and posttransplant data including development of
recoarctation of the aorta, interventions for recoarctation and the
most recent follow-up assessment of the aortic arch.
Results. Two hundred eighty-eight transplants were performed
on 279 children (follow-up 5 1,075 patient-years; range 0 to 133
months, median 43.7). Thirty-two of 152 patients (21%) who
underwent extended aortic arch reconstruction subsequently de-
veloped recoarctation. All but one patient developed recoarctation
within 2 years after transplant; 87% were hypertensive at presen-
tation. Of 30 patients who underwent intervention for recoarcta-
tion (balloon angioplasty [n 5 26] and surgical repair of recoarc-
tation [n 5 4]), 26 (87%) have remained recurrence-free (follow-
up 5 133 patient-years; range 8 to 106 months, median 47).
Conclusions. The high frequency of recoarctation after cardiac
transplantation with extended aortic arch reconstruction man-
dates serial echocardiographic evaluation of the aortic arch.
Patients typically present with systemic hypertension within the
first two years after transplantation. Balloon angioplasty is a safe,
effective and durable method of treatment.
(J Am Coll Cardiol 1998;32:509–14)
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Severe congenital structural defects of the left side of the heart
are major indications for referral to cardiac transplantation in
infancy. This group of defects often includes a hypoplastic
aortic arch and is typified by hypoplastic left heart syndrome
(HLHS). Studies have shown that in HLHS, ductal tissue
frequently extends circumferentially from the ductal orifice
into the aortic wall (1,2). Whereas transplant surgery in infants
with arch hypoplasia necessarily includes ductal tissue resec-
tion and extended aortic arch reconstruction beyond the
ductus arteriosus (Fig. 1), this may not be adequate to prevent
subsequent posttransplant recoarctation (3). This condition
has been addressed anecdotally, but has not been studied
systematically in a large population of transplant recipients
(4,5).
Our objectives were to study the incidence and mode of
presentation of posttransplant recoarctation of the aorta,
identify risk factors that predict recoarctation and examine the
results of intervention for posttransplant recoarctation.
Methods
The records of all cardiac allotransplants performed on
children younger than age 18 years over a 10-year period (from
November 1985 to November 1995) at Loma Linda University
Children’s Hospital and Medical Center were retrospectively
reviewed in August 1997. Recorded pre-transplant variables
included year of transplant, gender, age at transplant, cardiac
diagnosis and indication for transplantation, previous surgery
for coarctation and stent implantation in the ductus arteriosus.
Transplant operation reports were reviewed for the identity of
the surgeon, the need for extended aortic arch reconstruction,
donor and recipient weight and donor ischemic time. Patient
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charts were reviewed for the date, type and results of the most
recent diagnostic test that visualized the aortic arch. Autopsy
reports were reviewed for references to recoarctation. For
patients who had undergone repeat transplantation, the sur-
geon’s description of the aortic arch at repeat transplantation
was used as the most recent diagnostic test for the first
transplant.
For all patients who developed posttransplant recoarcta-
tion, the mode of presentation, date of diagnosis, indications
for intervention, date of intervention, type (surgery or balloon
angioplasty) and number of interventions, intraprocedure and
postprocedure complications and duration of follow-up were
noted. All aortic arch angiograms were reviewed to assess
recoarctation anatomy prior to intervention.
Surgical technique. The techniques used for cardiac trans-
plantation and extended aortic arch reconstruction were sim-
ilar to those described previously (3); a continuous 7-0
polypropylene suture was used for aortic arch reconstruction.
In the past year, the surgical technique has been modified to
decrease the circulatory arrest time; thus, only the aortic and
left atrial anastomoses are being performed under circulatory
arrest.
Screening for posttransplant recoarctation. Recoarctation
was defined as anatomic narrowing in the juxtaductal region of
the thoracic aorta, with or without a significant pressure
gradient across the area of narrowing. All patients who under-
went transplantation were screened for recoarctation using
clinical criteria including arm-leg blood pressure differentials.
Echocardiographic surveillance including Doppler evaluation
of the aortic arch was scheduled 1, 3, 6 and 12 months and then
annually after transplant. In addition, echocardiography or
cardiac catheterization, or both, were performed when indi-
cated by clinical criteria.
Treatment of posttransplant recoarctation. Balloon angio-
plasty of recoarctation was performed using techniques similar
to those previously described (6–9). Angioplasty catheter
selection criteria were operator-dependent; five different op-
erators performed balloon angioplasty over the 10-year study
period. The procedure for surgical repair of posttransplant
recoarctation consisted of resection followed by end-to-end
repair of recoarctation.
Statistical methods. Because continuous variables were
not normally distributed, nonparametric testing with the
Mann-Whitney U test was performed. Discrete variables were
analyzed using chi-square analysis. Analysis of variance was
used wherever appropriate. Kaplan-Meier survival curves were
used to determine freedom from recoarctation, and separately,
to determine freedom from reintervention after the initial
intervention for recoarctation. The equality of event-free sur-
vival (freedom from recoarctation) between HLHS and non-
HLHS patients was compared using the log-rank test. Patients
were censored at the date of first intervention for recoarctation
(for those who have developed recoarctation), or at the date of
the most recent study confirming absence of recoarctation (for
those who have not developed recoarctation).
Results
Two hundred eighty-eight cardiac transplants were per-
formed on 279 children during the study period, including 9
retransplants. The median duration of follow-up was 43.7
months (range 0 to 133), representing a total of 1,075 patient-
years of follow-up. The pretransplant cardiac diagnosis was
HLHS in 128 patients (44%), other structural heart defects in
108 patients (38%), cardiac tumors in 3 patients (1%) and
cardiomyopathy in 49 patients (17%) including 9 retransplants
Abbreviations and Acronyms
HLHS 5 hypoplastic left heart syndrome
Figure 1. Schematic diagram of extended
aortic arch reconstruction as part of cardiac
transplantation for aortic arch hypoplasia.
Left panel, severe aortic arch hypoplasia
extends up to the level of the insertion of
the ductus arteriosus into the descending
thoracic aorta. Cardiopulmonary bypass
cannulas are in place and snares have been
placed around the proximal ends of the
aortic arch branches. Right panel, the donor
atria are anastomosed to the posterior collar
of recipient atria. An extended length of
donor aorta is used to reconstruct the aortic
arch; anastomotic suture lines are seen on
the undersurface of the arch, extending
beyond the level of the ductus arteriosus.
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for coronary arteriopathy (n 5 8) and early posttransplant
graft failure (n 5 1).
The most recent test available for the 197 children who are
alive to date was catheterization in 165 and echocardiography
in 32. Autopsy data were available for 74 of the 82 children
who died; either the most recent cardiac catheterization (n 5
6) or echocardiographic data (n 5 2) were used for the
remaining 8 patients.
Incidence and presentation. Posttransplant recoarctation
occurred in 32 of 152 patients (21.1%) who underwent aortic
arch reconstruction; there were no cases of posttransplant
recoarctation among patients who did not require prior arch
augmentation (0 of 136 patients, p , 0.0001). Of 32 patients
with recoarctation, antemortem diagnosis was possible in 30
cases. Twenty-nine patients were diagnosed at less than 2 years
after transplant; one patient first developed recoarctation 5
years after transplant (median time from transplant to diagno-
sis 8.7 months, range 0 to 60.8). Twenty-six of 30 patients
(87%) exhibited systolic hypertension (systolic blood pressure
greater than or equal to the 95th percentile for age and
gender) within the 2 months before intervention (10). The
remaining 4 children were asymptomatic and in these, reco-
arctation was first detected by surveillance echocardiograms
(n 5 3) or catheterization (n 5 1).
Two patients were not diagnosed antemortem; recoarcta-
tion was found at autopsy. A 2-year-old child who underwent
transplantation for HLHS was followed for respiratory symp-
toms (tachypnea and dyspnea attributed to reactive airways
disease) until her death; severe recoarctation was found at
autopsy. The second patient was an infant with interrupted
aortic arch who underwent transplant surgery and did not wean
off cardiopulmonary bypass; at autopsy, residual coarctation
was found distal to the arch reconstruction. Undiagnosed
coarctation was probably a significant contributor to the de-
mise of both children.
Risk factors. Of the 152 patients requiring arch reconstruc-
tion, the pretransplant diagnosis was HLHS in 128, 28 of whom
(21.9%) developed recoarctation. The remaining 24 patients
requiring arch reconstruction had structural heart defects
other than HLHS (including double-outlet right ventricle with
mitral atresia, unbalanced atrioventricular canal defects or
other malformations); 4 of these patients (16.7%) developed
recoarctation. The difference between recoarctation rates for
the two diagnostic groups (HLHS vs. non-HLHS) was not
statistically significant. Thus, the need for extended arch
reconstruction predicted subsequent recoarctation regardless
of specific pretransplant cardiac diagnosis. The Kaplan-Meier
survival function showing freedom from recoarctation for all
patients undergoing extended arch reconstruction is shown in
Figure 2. Log-rank analysis revealed no differences between
rates of freedom from recoarctation for patients with versus
without HLHS (p 5 0.57).
Patients who developed recoarctation were younger at the
time of transplantation (median age at transplant 0.8 months,
range 0.2 to 3.6) than those who were recoarctation-free
(median age at transplant 1.7 months, range 0 to 216, p 5
0.001). Reflecting this, recipient weight at transplantation was
lower in the recoarctation (median 3.65 kg, range 2.1 to 5.5)
than in the recoarctation-free (median 3.9 kg, range 2.1 to
48 kg; p 5 0.03) group. Similarly, donor weight was lower in
the recoarctation (median 6 kg, range 2.2 to 13) than in the
recoarctation-free (median 7.4 kg, range 2.1 to 59 kg; p 5
0.005) group. Other tested variables including pretransplant
stent implantation in the ductus arteriosus, pretransplant
surgery for coarctation, the diagnosis of interrupted aortic
arch, ischemic time, year of transplant, identity of the surgeon
and donor-recipient weight ratio were not found to be signif-
icant predictors of recoarctation.
Nature of posttransplant recoarctation. Aortic arch an-
giography before intervention revealed a discrete area of
recoarctation in 29 of 30 patients. This area was distal to the
origin of the left subclavian artery in 27 patients, and was
proximal to the origin of the left subclavian artery in 2. One
patient had long segment recoarctation. In a separate instance,
there was an additional area of stenosis in the ascending aorta.
Intervention for posttransplant recoarctation. Thirty pa-
tients underwent 35 procedures; 4 patients required more than
one intervention for recoarctation (one patient has required
three interventions to date). Transcatheter balloon angioplasty
was performed in 31 of 35 patients (89%). Surgery was
Figure 2. Kaplan-Meier curve showing freedom from in-
tervention for recoarctation after cardiac transplantation
with extended reconstruction of the aortic arch. Values are
shown as mean 6 95% confidence limits (1.96zSEM).
Numbers above the x-axis represent the number of uncen-
sored patients at each time point.
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performed in 4 patients: 2 were diagnosed with recoarctation
early (less than 2 months) after transplantation, one patient
had obstruction at multiple levels including the ascending
aorta and another patient had no arterial access.
Balloon angioplasty resulted in an immediate decrease in
the median peak gradient (measured at catheterization) from
35 mm Hg (range 10 to 123) to 2 mm Hg (range 0 to 34; p ,
0.0001). Median systolic blood pressure proximal to the reco-
arctation decreased from 124 mm Hg (range 95 to 198) before
dilation to 110 mm Hg (range 80 to 156; p , 0.001) immedi-
ately after dilation. Median systolic blood pressure distal to the
recoarctation increased from 90 mm Hg (range 42 to 148)
before dilation to 103 mm Hg (range 69 to 137; p 5 0.003)
immediately after dilation. At the most recent follow-up study,
median systolic blood pressure was 104 mm Hg (range 84 to
140) proximal to the recoarctation, and was 100 mm Hg (range
84 to 140) distal to the recoarctation. The median peak systolic
pressure gradient across the site of recoarctation repair was
0 mm Hg (range 0 to 8).
One patient developed transient complete heart block after
introduction of a wire into the left ventricle, requiring chest
compressions and chemical resuscitation; the patient subse-
quently recovered uneventfully. Postangioplasty cineangio-
grams revealed intimal tears in two other patients. One of
these patients subsequently underwent surgical repair for
multilevel aortic obstruction; the other patient has shown no
evidence of aortic luminal irregularity on follow-up angiogra-
phy. There have been no cases of aortic aneurysms at the
angioplasty site.
Patients have been followed for 53 6 27 months (range 8.4
to 105.8) (total of 132.7 patient-years) since the initial inter-
vention for recoarctation. Twenty-six of 30 children (87%)
have remained recurrence-free; 4 children (13%) have re-
quired more than one procedure. One of these patients had
recoarctation, which responded well to balloon angioplasty,
and recurrent ascending aortic stenosis, which required two
subsequent operations. The other three patients who required
more than one intervention for recoarctation had all under-
gone balloon angioplasty, and developed recoarctation within
12 to 18 months after the initial intervention. Kaplan-Meier
analysis of freedom from recoarctation after the initial inter-
vention for posttransplant recoarctation of the aorta is shown
in Figure 3.
Discussion
Substrate for posttransplant recoarctation. The initial op-
eration for patients with aortic arch hypoplasia associated with
a functionally single ventricle, either the Norwood operation or
cardiac transplantation, includes aortic arch reconstruction
extending beyond the level of the ductus arteriosus (3,11). In
HLHS, ductal tissue extends into the thoracic aorta proximally
and distally for variable distances, and may encircle the aorta
completely; this aortic extension of ductal tissue may be as
wide as the ductus itself (1,2). The surgical procedure of
cardiac transplantation with arch reconstruction includes re-
section of the coarctation, removing as much ductal tissue as
possible, leaving behind a small posterior rim of the aortic
circumference to allow continuity of the aortic wall (3).
However, the microscopic extension of ductal tissue into the
aortic wall may not be evident to inspection, thus limiting its
complete removal. In addition, the posterior remnant of the
aortic wall may contain ductal tissue; contraction of ductal
tissue and postoperative scarring of the aortic wall are proba-
bly the substrate for the development of posttransplant reco-
arctation. This condition has been addressed in a case report
and in a posttransplant follow-up series but has not been
systematically analyzed (4,5). In the current study, 20.3% of
patients with aortic arch hypoplasia who underwent transplan-
tation with extended aortic arch reconstruction developed
recoarctation of the aorta. This is comparable to the 7% to
29% incidence of aortic arch obstruction following the Nor-
wood operation reported from several institutions using the
univentricular approach for palliation of HLHS (12–15). Re-
coarctation occurs more often after extended aortic arch
reconstruction than after surgical repair (end-to-end anasto-
mosis or left subclavian artery flap repair) of infantile coarc-
tation; recurrence rates in the latter group have been reported
at approximately 14% (16). The high incidence of recoarcta-
tion in patients who have undergone extended arch reconstruc-
tion emphasizes the need for methodical surveillance.
Figure 3. Kaplan-Meier curve showing freedom from reinter-
vention for recoarctation after balloon angioplasty/surgical
repair of posttransplant recoarctation. Values are shown as
mean 6 95% confidence limits (1.96zSEM). Numbers above
the x-axis represent the number of uncensored patients at
each time point.
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Diagnosis of posttransplant recoarctation. The diagnosis
of posttransplant recoarctation poses several challenges. Pa-
tients in the current study were typically less than 2 years old at
presentation; accurate blood pressure measurement is a logis-
tic challenge in this age group. Femoral arterial stenosis or
occlusion after previous cardiac catheterization or indwelling
catheters may obscure the utility of arm-leg differentials in
blood pressure. Besides, hypertension may be multifactorial in
the setting of immunosuppressive medications and possible
renal impairment; thus, the implications of elevated blood
pressure may not be readily apparent. Untreated recoarctation
of the aorta frequently leads to left ventricular hypertrophy,
leading to an echocardiographic profile similar to that seen
with allograft rejection. This may lead to more rigorous
immunosuppression, with the attendant probability of exacer-
bating hypertension as an untoward effect. Careful, serial
echocardiographic assessment of anastomotic sites is essential
after pediatric cardiac transplantation, particularly after ex-
tended reconstruction of the aortic arch; at our institution,
anastomotic sites are evaluated 1, 3, 6 and 12 months, and then
annually after transplant. In addition, the protocol for trans-
catheter surveillance includes annual aortic arch angiography
in all patients who have undergone extended arch reconstruc-
tion at transplant.
Treatment of posttransplant recoarctation. Balloon angio-
plasty has been performed to treat native coarctation of the
aorta as well as recoarctation after a variety of initial proce-
dures ranging from coarctation repair to the Norwood opera-
tion, with good immediate results (17–21). Fletcher et al. (17)
reported a series of 102 patients who underwent angioplasty
for native coarctation; 29% of patients either had inadequate
relief of coarctation or subsequently developed recoarctation.
A multicenter study comparing balloon angioplasty for native
versus recurrent coarctation revealed an acute suboptimal
outcome in 19% of 422 native coarctations, and in 25% of 548
recurrent coarctations (18). Yetman et al. (22) recently re-
ported a series of 90 consecutive patients who underwent
balloon angioplasty for aortic recoarctation after attempted
surgical repair; previous surgical techniques included subcla-
vian artery flap repair, end-to-end anastomosis and patch
aortoplasty. Twenty-eight percent of patients with an optimal
early result required reintervention at long-term follow-up; the
presence of transverse arch hypoplasia detected at the time of
angioplasty was associated with suboptimal long-term out-
come. In the current study, initial treatment of coarctation of
the aorta consisted of extended aortic arch reconstruction at
the time of transplantation. Thus, the subsequent development
of coarctation in these patients is best classified as recoarcta-
tion rather than as new coarctation. We were unable to assess
for transverse arch hypoplasia in this cohort because the
procedure of transplantation with extended arch reconstruc-
tion modifies the contour of the aortic arch; in addition, only
four patients required additional procedures on the aortic
arch, thus making it difficult to identify risk factors for subop-
timal outcome. The current study demonstrates the safety,
efficacy and durability of balloon angioplasty in most cases of
posttransplant recoarctation of the aorta. Our results compare
favorably with published results of balloon angioplasty for
native as well as recurrent coarctation of the aorta (17–
19,21,22).
Limitations. The limitations of this study stem from its
retrospective nature, which made it impossible to standardize
the procedure of balloon angioplasty for recoarctation. How-
ever, extended and complete follow-up has been obtained in
every patient in this large cohort. Of patients undergoing arch
reconstruction, we were unable to identify those at risk for
developing recoarctation. A prospective echocardiographic
morphometric analysis may prove useful in assessing such risk
factors.
Conclusions. Recoarctation of the aorta occurs often in
children requiring cardiac transplantation with extended aortic
arch reconstruction. Patients typically present with systemic
hypertension within the first 2 years after transplantation.
Careful, serial echocardiographic assessment of anastomotic
sites is essential after pediatric cardiac transplantation, partic-
ularly following extended reconstruction of the aortic arch.
Balloon angioplasty is a safe, effective and durable method of
treatment.
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